Image

Using Transcranial Magnetic Stimulation to Treat Stuttering

Using Transcranial Magnetic Stimulation to Treat Stuttering

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to learn if repeated transcranial magnetic stimuli (rTMS) can treat stuttering in adults. The main questions it aims to answer are:

  • Will there be changes in the brains of people who stutter because of the treatment?
  • Will any changes in the brain result in less stuttering?

Participants will:

  • Visit the lab 3 times before treatment for tests
  • Complete 10 rTMS sessions
  • Visit the lab 2 times after treatment for tests

Description

Measures must be obtained to in preparation for TMS treatment. Structural MRI and resting-state functional MRI (rsfMRI) recordings will be obtained from the participant, and they will undergo a neuronavigational session to determine best placement for the electrodes.

MRI/rsfMRI recordings: The structural MRIs will be obtained and used for TMS neuronavigation. Resting-state functional MRI will be recorded for 8 min with the eyes open. rTMS will be delivered at 10 Hz for 10 min with a stimulation intensity of 120% of the resting motor threshold (rMT).

Neuronavigation: The TMS coil will be navigated with a neuronavigation system using the individual MRIs. rTMS targets: rTMS will be delivered to the left inferior frontal gyrus (IFG). We will use the neuronavigation system to identify the IFG.

Three pre-treatment and 2 post-treatment sessions will each obtain data from the following measurements:

  • rs-EEG: rs-EEG responses will be recorded with eyes open for 5 minutes using a 64-channel EEG system.
  • Eye tracker: eye gaze fixations, dwell time, saccades, and gaze durations will be recorded while the participant completes several behavioral phonological memory tasks.
  • Spontaneous speech sample will be obtained to determine percent syllables stuttered.

Eligibility

Inclusion Criteria:

  • Age from 18 to 65 years
  • Self-identifies as a person who currently stutters
  • Right-handed or left-handed
  • Normal hearing and (corrected) vision
  • Able to understand and give informed consent
  • Monolingual English speaker

Exclusion Criteria:

  • Cardiac pacemaker or pacemaker wires; neurostimulators; implanted pumps
  • Metal in the body (rods, plates, screws, shrapnel, dentures, IUD) or metallic particles in the eye
  • Facial tattoos
  • Not having medical insurance
  • Surgical clips in the head or previous neurosurgery
  • Any magnetic particles in the body
  • Cochlear implants
  • Prosthetic heart valves
  • Epilepsy or any other type of seizure history
  • History of significant head trauma (i.e., extended loss of consciousness, neurological sequelae)
  • Known structural brain lesions
  • Pre-existing speech, language, or neurological disorder (except for stuttering)
  • Significant other disease (heart disease, malignant tumors, mental disorders)
  • Significant claustrophobia; Ménière's disease
  • Women who are trying to get pregnant and sexually active women (of reproductive age) not on a reliable contraceptive
  • Pregnancy, breastfeeding
  • Medications increasing the risk for seizures
  • Non-prescribed drug use
  • Use of recreational drugs such as medical marijuana
  • Failure to perform the behavioral tasks or neuropsychological evaluation tests
  • Prisoners

Study details
    Stuttering
    Adult

NCT07389694

Kansas State University

14 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.